The General Anesthesia Drugs Market is expected to be adversely impacted by the coronavirus outbreak. The pandemic has largely suspended anesthetic medical procedures, of a non-urgent nature, substantially reducing demand for general anesthesia drugs in the short term. Closure of clinics in nationwide lockdowns, and postponed elective medical procedures in the near future will hamper the general anesthesia drugs market. Recovery of the industry is dependent on the severity and duration of the disease.
"Tech advancements in drug delivery apparatus, research on patient monitoring devices, and targeted drugs for patients during and after the use of anesthesia, and reduction of side effects from modern anesthetic drugs are providing impetus to growth of the general anesthesia drugs market," says the FMI analyst.
General Anesthesia Drugs Market - Key Takeaways
- Propofol is a highly popular general anesthesia drug, aided by low risk of side effects.
- Injectables remain the common general anesthesia drug delivery method, owing to superior efficacy properties.
- Asia Pacific is a leading market for general anesthesia drugs, owing to rising demand for surgical intervention in chronic diseases such as diabetes.
General Anesthesia Drugs Market - Key Driving Factors
- Rising cases of cardiovascular diseases is a key factor supporting the sales of general anesthesia drugs.
- A rapidly ageing population with a wide range of chronic ailments generates demand for general anesthesia drugs.
- Investments into research for drug delivery methods and drug formulations support market growth.
General Anesthesia Drugs Market - Key Constraints
- Lack of standardization in terms of anesthesia management techniques hinders market developments.
- High cost of branded anesthetics and associated medical procedures holds back market growth.
The Anticipated Impact of Coronavirus
Anesthetic practices have been substantially impacted by the coronavirus pandemic. Numerous clinics have had to suspend their operations, as elective medical procedures have been directed to be postponed. On the other hand, surgical interventions for aged covid-19 patients will generate opportunities, which will partially mitigate losses incurred during this crisis period.
Competition Landscape
Players in the general anesthesia drugs market include but are not limited to Abbott Laboratories, AbbVie Inc., Astra Zeneca Plc, Baxter International Inc., and Fresenius SE & C. KGaA. Developers are investing in investing in research for product development, and wider scope of application. For instance, sevoflurane has been found to improve outcomes of patients with sepsis.
More About the Report
The FMI's market research report offers detailed insights on general anesthesia drug s market. The market is scrutinized on the basis of drug class (propofol, sevoflurane, dexmedetomidine, desflurane, remifentanil, midazolam, and others), route of administration (intravenous anesthesia, and inhaled anesthesia), and end user (hospitals, ambulatory surgical centers, and specialty clinics) across seven key regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa).
Read More@ https://www.futuremarketinsights.com/reports/general-anesthesia-drugs-market
The rising prevalence of cancer, rapid growth in geriatric population, and increasing number of emergency surgeries are some of the major factors driving the growth of the US general anesthesia drugs.The US general anesthesia drugs market size is projected to reach USD 2.4 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 3.4% during the forecast period.Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=713Market Segmentation: -Intravenous anesthesia drugs accounted for the largest share in the US general anesthesia drugs market in 2019.Based on the route of administration, US general anesthesia drugs market is categorized into inhalational anesthesia drugs and intravenous anesthesia drugs.
The inhalational anesthesia drugs is further categorized into sevoflurane, desflurane, isoflurane and nitrous oxide.
Similarly, intravenous anesthesia drugs are further categorized into propofol, benzodiazepines, ketamine, methohexital sodium and others intravenous general anesthesia drugs.
The intravenous segment accounted for the largest share of the market.
General intravenous anesthesia drugs are less expensive and do not require expensive machines for administration which contributes to the high market share of the segment.Hospitals accounted for the largest share in the US general anesthesia drugs market in 2019Based on end user, the US general anesthesia drugs market has been segmented into hospitals and ambulatory surgery centers.
The hospitals segment accounted for the largest share of the US general anesthesia drugs market in 2019.
General anesthesia drugs are administered to a patient to bring state of reversible unconsciousness and unresponsiveness before and during surgery.
Sometimes based on the condition, both the routes are used simultaneously to anesthetize the patient.
General anesthesia drugs are intended to bring about analgesia or pain relief, amnesia, reversible unconsciousness, motionlessness, and inhibition of autonomic nervous system such as increased blood pressure, heart rate, and sweating, and to perform easier and safer surgery.
Read Report Overview – https://www.transparencymarketresearch.com/general-anesthsia-drugs-market.htmlCurrently, there is a lack of standardization for technique in general anesthesia management.
Further, the technological advancements in drug delivery devices, development of specific targeted drugs and patient monitoring devices for monitoring physiological parameters of patients during and after anesthesia, and minimized side effects of anesthetic drugs are drivers which are likely to boost the market growth during the forecast period.
However, lack of health care facilities in underdeveloped countries and in remote areas and few anesthetic doctors and certified anesthetic nurses per capita of population are anticipated to restrain the growth of the general anesthesia drugs market.
General Anesthesia Drugs Market:WiseGuyReports.com adds “Global General Anesthesia Drugs Market Research Report 2020 Analysis and Forecast 2025” reports to its database.Executive SummaryAn insightful overview of the General Anesthesia Drugs market gives a detailed look into the industry and how it gets impacted by various factors.
This overview includes a general definition that helps in the preliminary assessment of the industry and bears impacts caused by various factors.
It also encompasses various features that make the product so desirable among various end user communities.
The technological aspect that ensures better production and growth margin and simplifies the end-to-end services has been covered in the report as well.
Furthermore, it develops the study by including all the latest trends and competitive analysis as a part of the market study and predicts certain moves during the forecast period covering 2020 to 2025.
Market DynamicsThe market dynamics section has its focus set on various factors that could impact the global outcome of the General Anesthesia Drugs market.
